Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Gholami A; Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.; Biotechnology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Subjects: Adalimumab/Adalimumab/Adalimumab/*therapeutic use ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy ; Biological Products/Biological Products/Biological Products/*therapeutic use
-
Source:
BioMed research international [Biomed Res Int] 2021 Nov 28; Vol. 2021, pp. 4450162. Date of Electronic Publication: 2021 Nov 28 (Print Publication: 2021).Publisher: Hindawi Pub. Co Country of Publication: United States NLM ID: 101600173 Publication Model: eCollection Cited Medium: Internet ISSN:
Record details
-
Authors :
Nassar-Sheikh Rashid A; Zaans Medical Center, Zaandam and Emma Children's Hospital, Amsterdam UMC, Pediatric Immunology, Rheumatology and Infectious Diseases, University of Amsterdam, Amsterdam, The Netherlands. .; Schonenberg-Meinema D
Subjects: Adalimumab*/Adalimumab*/Adalimumab*/immunology ; Adalimumab*/Adalimumab*/Adalimumab*/therapeutic use ; Arthritis, Juvenile*/Arthritis, Juvenile*/Arthritis, Juvenile*/drug therapy
-
Source:
Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2021 Apr 29; Vol. 19 (1), pp. 59. Date of Electronic Publication: 2021 Apr 29.Publisher: BioMed Central Country of Publication: England NLM ID: 101248897 Publication Model: Electronic Cited Medium: Internet ISSN: 1546-0096
Record details